DJIA 18,010.68 -115.44 -0.64%
NASDAQ 5,070.03 -27.95 -0.55%
S&P 500 2,107.39 -13.40 -0.63%
market minute promo

AbbVie Inc. (NYSE: ABBV)

66.59 -0.88 (-1.30%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ABBV $66.59 -1.30%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $67.22
Previous Close $67.47
Daily Range $66.39 - $67.52
52-Week Range $51.37 - $70.76
Market Cap $106.1B
P/E Ratio 60.24
Dividend (Yield) $2.04 (3.0%)
Ex-Dividend Date
Dividend Pay Date
04/13/15
05/15/15
Volume 9,450,784
Average Daily Volume 11,667,018
Current FY EPS $4.24

Sector

Industry

AbbVie Inc. (ABBV) Description

AbbVie Inc. Website: http://www.abbvie.com/

News & Commentary

3 Top Stocks for Investing in Silicon Valley

The fastest growers don't always get the headlines.

Larry Robbins' New Buys During Q1 2015

Larry Robbins' New buys in Q1 2015

Gilead's New HIV Combination Drug under Review in the EU - Analyst Blog

How We Decide Which DGI Stocks Are Core, Supporting And Auxiliary Holdings

Build a Billionaire Portfolio With 20 Favorite Stocks of Buffett, Icahn, Soros and Other Billionaire

Build a Billionaire Portfolio With 20 Favorite Stocks of Buffett, Icahn, Soros and Other Billionaires

How The Big Money Cashes In On Merck

AbbVie (ABBV) Stock Is the 'Chart of the Day'

Gilead's Sustainable Competitive Advantage

Gilead Sciences' long-term growth is being doubted by the Street because of the uncertainty surrounding the hep C market going forward. The biotech's top notch CEO John Martin, however, should be reason enough for investors to believe that company's best days lie ahead. Here's why.

OEF, ABBV, BA, BIIB: ETF Outflow Alert

See More ABBV News...